|
|
The drug delivery development news monitor, with an emphasis on emerging delivery technologies, market impact, and breakthroughs in delivery methods for new and existing therapeutics.
|
|
Audience:
Corporate executives at biotechnology, pharmaceutical, and drug-delivery technology companies of all sizes. |
Key Topics: Emerging delivery technologies & methodologies, market impact, breakthroughs in delivery methods for new and existing therapeutics |
Newsletter Frequency: Weekly |
Email Subscribers: 15,000+ |
Monthly page views: 15,500 |
Reader Demographics
Company Type
Pharmaceutical - 32%
CRO/CMO/Contract Outsourcing - 20%
Biotechnology - 15%
Healthcare/Medical - 7%
Marketing / Ad Agency - 3%
Financial/Legal - 3%
Devices/Diagnostics - 2%
IT/IS/Bioinformatics - 2%
Instruments/Materials - 3%
Government - 1%
Other - 12%
Job Function
Manufacturing / Packaging - 16%
CEO / C-Level Executive - 14%
QA / QC - 13%
Clinical Operations - 12%
Pharma Sales - 9%
R&D / Engineering - 7%
Licensing / Biz Dev - 6%
Marketing / Brand Mgmt - 5%
Regulatory / Compliance / Safety - 6%
IT / IS / Bioinformatics - 2%
Medical Affairs - 1%
Finance / Legal - 1%
Other - 8%
Region
North America - 66%
Europe - 11%
Asia - 20%
Australia/NZ - 1%
Other - 2%
